Bio-Rad Laboratories (BIO) total liabilities

Total liabilities · fiscal 2025
$3.12B

Bio-Rad Laboratories (BIO) had total liabilities of $3.12B at the end of fiscal 2025 (December 31, 2025). That is 11.7% higher than the $2.79B of fiscal 2024. Figures as of 18 Nov 2026, 23:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$3.12B
Change on fiscal 2024
+11.7%
Growth, 5 years
+0.2% a year
Growth, 10 years
+9.9% a year
Highest on record
$4.11Bfiscal 2021
Lowest on record
$1.16Bfiscal 2014
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bio-Rad Laboratories total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 0.2% a year; over ten years the rate was 9.9% a year. Across the 17 fiscal years on record (2009–2025), the highest was $4.11B in fiscal 2021 and the lowest $1.16B in fiscal 2014.

History · 17 fiscal years

Total liabilities by fiscal year

Bio-Rad Laboratories total liabilities, year by year

Bio-Rad Laboratories (BIO) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$3.12B 11.7% up
2024$2.79B 21.4% down
2023$3.56B 8.5% down
2022$3.89B 5.5% down
2021$4.11B 33.0% up
2020$3.09B 37.2% up
2019$2.25B 41.7% up
2018$1.59B 18.5% up
2017$1.34B 5.6% up
2016$1.27B 4.3% up
2015$1.22B 5.5% up
2014$1.16B 3.8% down
2013$1.20B 15.8% down
2012$1.43B 5.6% up
2011$1.35B 11.2% down
2010$1.52B 21.1% up
2009$1.26B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Bio-Rad Laboratories and comparable companies
CompanyTotal liabilitiesFiscal year
Ensign Group ENSG$3.23B2025
Vaxcyte PCVX$317.21M2025
Bio-Rad Laboratories BIO$3.12B2025
Molina Healthcare MOH$11.50B2025
Spyre Therapeutics SYRE$62.55M2025
Qiagen QGEN$2.50B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BIO

Bio-Rad Laboratories, figure by figure

Bio-Rad Laboratories (BIO) overview: price, valuation and scorecardAll health care companies by market value

Bio-Rad Laboratories total liabilities: questions and answers

How large are Bio-Rad Laboratories's total liabilities?

Bio-Rad Laboratories (BIO) had total liabilities of $3.12B at the end of fiscal 2025 (December 31, 2025). That is 11.7% higher than the $2.79B of fiscal 2024.

What is the growth rate of Bio-Rad Laboratories's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 0.2% a year; over ten years the rate was 9.9% a year.

What are the highest and lowest total liabilities figures on record for Bio-Rad Laboratories?

Across the 17 fiscal years on record (2009–2025), the highest was $4.11B in fiscal 2021 and the lowest $1.16B in fiscal 2014.

How is Bio-Rad Laboratories's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Bio-Rad Laboratories it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Rad Laboratories (BIO) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/BIO/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.